What Happens During Manufacturing Scale-Up?

Manufacturing scale-up is the process of converting an approved laboratory formula into a repeatable commercial production process. It is not simply a matter of multiplying every ingredient by a larger number. Equipment, mixing, heating, cooling, addition order, batch depth, filling and quality controls behave differently when a product moves from a bench sample to a manufacturing vessel.

Scale-up is the point where formulation and manufacturing meet. The formulator’s instructions must be translated into a process that can be performed safely and consistently using the manufacturer’s equipment. Raw materials, packaging and finished-product specifications must also be ready for commercial use.

This guide explains what happens during manufacturing scale-up, why products can behave differently at volume, what information a manufacturer needs and how Australian brands can reduce delays and avoid costly production surprises.

Why laboratory success does not guarantee production success

A laboratory sample may be prepared with a small overhead mixer, hotplate, hand tools or bench homogeniser. Commercial production may use a jacketed vessel, high-shear mixer, transfer pump and filling line. The underlying formula is the same, but the physical environment is not.

At larger scale:

• heating and cooling take longer;
• temperature may vary through the vessel;
• mixing energy is distributed differently;
• powders can hydrate, disperse or clump differently;
• air can be incorporated or removed differently;
• volatile ingredients may need different handling;
• the order and location of additions become more important;
• transfer through pumps and hoses can affect the product;
• viscosity can change before, during or after filling.

A responsible manufacturer assesses these factors rather than assuming that the bench method will reproduce itself automatically.

When does scale-up begin?

Scale-up planning begins during formulation. A commercially minded formulator considers the likely manufacturing equipment, batch size, raw materials, temperature controls and filling method while developing the sample.

Formal scale-up work usually begins after the product brief and formula are sufficiently stable. Packaging direction, specifications and testing decisions should also be advanced enough to guide production. Moving into scale-up while the brand is still changing the product concept creates unnecessary rework.

Information required before scale-up

Approved formula

The manufacturer needs a controlled formula identifying the materials, quantities and applicable tolerances. Trade names, supplier information and material grades may matter; two ingredients with similar names are not automatically interchangeable.

Manufacturing method

The method should describe addition order, mixing, heating, cooling, hold times, target temperatures and other critical steps. Instructions must be detailed enough to transfer the process while allowing the manufacturer to adapt it to approved equipment.

Finished-product specifications

Specifications describe how the approved product should be assessed. Relevant criteria may include appearance, colour, odour, flavour, pH, viscosity, density, fill weight or other category-specific measures.

Approved reference sample

A retained approved sample provides a sensory and visual reference. It should be identified by code and approval date. An unlabelled container or an early sample from before the final revision is not a reliable manufacturing standard.

Packaging and filling information

The manufacturer needs the component specification, fill size, closure, label or decoration requirements and expected finished quantity. The product must move through the filling equipment and dispense acceptably from the retail pack.

Testing and release plan

Confirm which tests or checks apply to the bulk, filled units or production batch and whether any results are required before release. Testing responsibilities should be documented rather than assumed.

Step 1: Technical transfer review

The manufacturer reviews the formula, method, materials, specifications, packaging and intended batch size. The team identifies equipment requirements, critical process parameters, likely risks and any missing documentation.

If a formula was developed by another provider, the receiving manufacturer also needs to confirm that the brand has the right to use it and that sufficient transfer information is available. An ingredient list alone is not a manufacturing formula.

Read manufacturer, formulator and laboratory: what is the difference? for a clearer explanation of partner responsibilities.

Step 2: Raw-material review

Materials need to be available in the appropriate form, grade and quantity. Commercial suppliers may offer different pack sizes or lead times from those used during development. Documentation, storage and handling requirements also need to be considered.

A proposed substitution must be reviewed technically. Changing a surfactant, emulsifier, flavour, botanical extract, protein or thickener can affect performance even when the substitute appears similar on paper.

Step 3: Equipment selection

The manufacturer selects a vessel and mixing system suited to the formula and batch size. The vessel should allow appropriate working volume, heating or cooling and ingredient addition. The mixer must provide the necessary movement without creating unwanted aeration or damaging the product.

Equipment selection also considers transfer and filling. A product may look correct in the vessel but be difficult to pump through hoses or dispense accurately into the chosen component.

Step 4: Scaling the manufacturing method

Ingredient quantities are recalculated for the commercial batch, but process parameters cannot always be scaled linearly. Mixing speed, mixing time, temperature ramp and cooling rate need to reflect the equipment and product behaviour.

The team identifies critical stages such as:

• complete powder dispersion;
• phase heating and emulsification;
• hydration of gums or thickeners;
• timing of heat-sensitive ingredients;
• pH adjustment;
• fragrance or flavour addition;
• de-aeration or resting;
• temperature and viscosity at filling.

Step 5: Pilot or first commercial batch

The appropriate first-scale approach depends on the project and available equipment. Some products move through a pilot stage, while others are assessed during a controlled first commercial batch. The objective is to confirm that the formula and method can deliver product matching the approved requirements at the intended scale.

Observations should be recorded throughout manufacture. The team may check appearance, temperature, pH, viscosity, flavour, odour, yield or other relevant criteria at defined stages.

Step 6: Bulk assessment

The manufactured bulk is compared with the specification and approved reference. Differences do not always mean failure; some products continue to develop viscosity or appearance as they cool or rest. The manufacturer needs to understand the expected behaviour before deciding whether an adjustment is appropriate.

Uncontrolled corrections should be avoided. Any approved adjustment should be documented so the process can be repeated.

Step 7: Filling assessment

Filling is part of scale-up because the product must move consistently through production equipment and into the approved component. Viscosity, foam, temperature, particulates and product settling can affect fill accuracy and line speed.

The team may assess:

• pumpability and transfer losses;
• fill-weight consistency;
• air pockets, dripping or stringing;
• closure and seal performance;
• appearance in transparent packaging;
• dispensing through the consumer pack;
• yield and expected finished units.

Step 8: Documentation and process refinement

After the run, the manufacturing record and observations are reviewed. The method may be refined to capture equipment settings, mixing stages, temperature windows, hold times or filling conditions that supported the result.

The goal is repeatability. Knowledge should be recorded in controlled production documents rather than remaining with one operator’s memory.

What can change during scale-up?

Viscosity

Heating, cooling, hydration, mixing energy and resting can all affect thickness. Viscosity also influences transfer, filling and consumer dispensing.

Colour and appearance

Ingredient dispersion, air, temperature and batch depth can make colour or clarity appear different. Suspended materials may settle or distribute differently.

Fragrance and flavour

Heat, addition timing, mixing and larger batch volume can change perception. Volatile materials require appropriate handling.

Foam and aeration

Commercial mixing may incorporate air, particularly in surfactant products. Entrained air can affect appearance, measured volume and filling.

Yield

Product remains in vessels, hoses, pumps and filling equipment. Expected yield and finished-unit range should account for normal production losses.

How testing connects to scale-up

Development testing and production checks answer different questions. The scale-up or commercial batch may be needed for production-representative assessments, retained samples or ongoing stability work. Changes made during scale-up should be reviewed for their effect on previous test relevance.

Retained samples and post-production observation

Retained samples create a traceable reference for the manufactured batch. The retention plan should identify the batch, component, storage conditions and relevant review period. Retention is not a substitute for a formal testing program, but it supports investigation if a later question arises about appearance, odour, flavour, viscosity, packaging or customer feedback.

Founders should also distinguish between the approved development sample, the bulk manufacturing sample and the filled finished product. Each represents a different stage. Comparing a finished unit with an unidentified early laboratory sample can lead to incorrect conclusions about whether scale-up succeeded.

The agreed retention and review process should be documented before release so responsibilities remain clear after finished goods leave the manufacturing facility.

Common scale-up mistakes

Using an incomplete formula transfer

An ingredient list without supplier grades, method, specifications and processing detail leaves the manufacturer to reconstruct essential information.

Changing materials without technical approval

A purchasing substitution can change viscosity, stability, flavour, colour or claims and may invalidate assumptions from development.

Using untested packaging

The final bulk may be correct but impossible to fill efficiently or dispense from the chosen component.

Expecting exact sample appearance immediately

Some products need defined cooling, resting or maturation before final assessment. Comparisons should follow the approved evaluation conditions.

Making undocumented corrections

An adjustment may rescue one batch but create future inconsistency if the reason, amount and process are not recorded.

Booking launch activity too tightly

First-scale production should include time for assessment, filling, quality review and contingency. Read a founder’s guide to manufacturing timelines.

How founders can prepare for scale-up

1. Approve the commercial brief and stop changing the product strategy.
2. Confirm formula ownership and transfer rights.
3. Maintain one controlled formula, method and specification.
4. Provide an identified approved reference sample.
5. Confirm the exact raw materials and suppliers where required.
6. Align the component, fill size and filling process.
7. Agree on test, quality and release responsibilities.
8. Provide sufficient packaging contingency for setup and losses.
9. Allow realistic time for the first-scale review.
10. Document approved changes before routine production.

The private label manufacturing checklist covers the complete preparation pathway.

Frequently asked questions

Is scale-up required for every custom formula?

A custom formula needs an appropriate transfer into commercial production. The exact scale-up pathway depends on the product, equipment, batch size and prior manufacturing history.

Can the commercial batch look different from the sample?

Differences can occur because of equipment, mixing, temperature, raw materials, aeration or evaluation timing. The product should be assessed against approved specifications and reference conditions.

Who is responsible for scale-up?

The manufacturer leads the commercial process, often with input from the formulator, quality team and brand. Responsibilities should be defined in the development and manufacturing scope.

Can a formula developed elsewhere be scaled by APL?

Potentially, subject to ownership rights, documentation, technical feasibility, materials, equipment, packaging and required development or testing work.

Does scale-up change the formula?

The goal is to reproduce the approved product, but a documented technical adjustment may sometimes be required. Any change should be reviewed for specifications, testing and claims.

When is a product ready for routine production?

When the formula, process, materials, specifications, packaging, quality checks and relevant testing or release requirements are sufficiently defined and approved.

Scale products with Australian Private Label

Australian Private Label supports private label skin care, custom cosmetic formulation, supplement development, testing and commercial manufacturing.

APL assesses scale-up as part of the complete project, including the formula, process, raw materials, packaging, quantity and quality requirements.

Important: This article provides general commercial information and is not technical, regulatory or legal advice for a specific formula. Scale-up, testing, specifications, release and manufacturing requirements must be confirmed for each project.